117 related articles for article (PubMed ID: 16521937)
1. [Tobacco smoking in patients with multiple sclerosis--preliminary study].
Wegrzyn D; Czarnywojtek A; Florek E; Sowiński J
Przegl Lek; 2005; 62(10):995-7. PubMed ID: 16521937
[TBL] [Abstract][Full Text] [Related]
2. [The role of tobacco smoking in etiology of multiple sclerosis--review study].
Wegrzyn D; Czarnywojtek A; Florek E
Przegl Lek; 2006; 63(10):1144-5. PubMed ID: 17288241
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of tobacco use among young adult males in India: a community-based epidemiological study.
Saddichha S; Khess CR
Am J Drug Alcohol Abuse; 2010 Jan; 36(1):73-7. PubMed ID: 20141401
[TBL] [Abstract][Full Text] [Related]
4. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
5. [Tobacco smoking and periodontitis].
Kurhańska-Flisykowska A; Soboczyńska K; Stopa J; Wiesiołowska A
Przegl Lek; 2005; 62(10):998-1000. PubMed ID: 16521938
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
7. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
Hedström AK; Bäärnhielm M; Olsson T; Alfredsson L
Neurology; 2009 Sep; 73(9):696-701. PubMed ID: 19720976
[TBL] [Abstract][Full Text] [Related]
8. [A case-control study of the influence of the smoking behaviour in multiple sclerosis].
Rodríguez Regal A; del Campo Amigo M; Paz-Esquete J; Martínez Feijoo A; Cebrián E; Suárez Gil P; Mouriño MA
Neurologia; 2009 Apr; 24(3):177-80. PubMed ID: 19418294
[TBL] [Abstract][Full Text] [Related]
9. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
[TBL] [Abstract][Full Text] [Related]
10. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and progression in multiple sclerosis.
Koch M; van Harten A; Uyttenboogaart M; De Keyser J
Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
[TBL] [Abstract][Full Text] [Related]
12. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
Brettschneider J; Jaskowski TD; Tumani H; Abdul S; Husebye D; Seraj H; Hill HR; Fire E; Spector L; Yarden J; Dotan N; Rose JW
J Neuroimmunol; 2009 Dec; 217(1-2):95-101. PubMed ID: 19879655
[TBL] [Abstract][Full Text] [Related]
14. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
[TBL] [Abstract][Full Text] [Related]
15. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
[TBL] [Abstract][Full Text] [Related]
16. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
17. ADC measurements in various patterns of multiple sclerosis lesions.
Phuttharak W; Galassi W; Laopaiboon V; Laopaiboon M; Hesselink JR
J Med Assoc Thai; 2006 Feb; 89(2):196-204. PubMed ID: 16579006
[TBL] [Abstract][Full Text] [Related]
18. The accuracy of self-reported smoking status assessed by cotinine test strips.
Parker DR; Lasater TM; Windsor R; Wilkins J; Upegui DI; Heimdal J
Nicotine Tob Res; 2002 Aug; 4(3):305-9. PubMed ID: 12215239
[TBL] [Abstract][Full Text] [Related]
19. Progression in multiple sclerosis: further evidence of an age dependent process.
Koch M; Mostert J; Heersema D; De Keyser J
J Neurol Sci; 2007 Apr; 255(1-2):35-41. PubMed ID: 17331540
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment and decline in different MS subtypes.
Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Polman CH
J Neurol Sci; 2006 Jun; 245(1-2):187-94. PubMed ID: 16643951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
